Evidence map›Paper›PMID 23509263›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Activity-enhancing mutations in an E3 ubiquitin ligase identified by high-throughput mutagenesis.

Lea M Starita, Jonathan N Pruneda, Russell S Lo, Douglas M Fowler, Helen J Kim, Joseph B Hiatt, Jay Shendure, Peter S Brzovic, Stanley Fields, Rachel E Klevit

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 204 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Deep structure-function analysis of the endonuclease Mus81 with dominant mutational scanning.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Review
  16. Biophysics-based protein language models for protein engineering.bioRxiv : the preprint server for biology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lea M StaritaHoward Hughes Medical Institute, Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Jonathan N Pruneda
Russell S Lo
Douglas M Fowler
Helen J Kim
Joseph B Hiatt
Jay Shendure
Peter S Brzovic
Stanley Fields
Rachel E Klevit
University of Washington · USHuman Genome Sciences (United States) · USHoward Hughes Medical Institute · US

Funding

TRAINING IN MOLECULAR AND CELLULAR BIOLOGYT32GM007270 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 1985 to 2020
$21.0M
TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2021
$20.7M
Structural and Functional Characterization of BRCA1/BARD1R01GM088055 · NIGMS · UNIVERSITY OF WASHINGTON · PI KLEVIT, RACHEL E · 2009 to 2020
$6.5M
Unconventional Interactions of Human Ubiquitin Conjugating EnzymesR01GM098503 · NIGMS · UNIVERSITY OF WASHINGTON · PI BRZOVIC, PETER S · 2012 to 2016
$1.5M
Howard Hughes Medical InstituteNIGMS NIH HHS 2T32 GM007270NIGMS NIH HHS P41 GM103533NIGMS NIH HHS R01 GM088055NIGMS NIH HHS R01 GM098503NIGMS NIH HHS T32 GM007270
6 · The paper itself

Abstract

Although ubiquitination plays a critical role in virtually all cellular processes, mechanistic details of ubiquitin (Ub) transfer are still being defined. To identify the molecular determinants within E3 ligases that modulate activity, we scored each member of a library of nearly 100,000 protein variants of the murine ubiquitination factor E4B (Ube4b) U-box domain for auto-ubiquitination activity in the presence of the E2 UbcH5c. This assay identified mutations that enhance activity both in vitro and in cellular p53 degradation assays. The activity-enhancing mutations fall into two distinct mechanistic classes: One increases the U-box:E2-binding affinity, and the other allosterically stimulates the formation of catalytically active conformations of the E2∼Ub conjugate. The same mutations enhance E3 activity in the presence of another E2, Ube2w, implying a common allosteric mechanism, and therefore the general applicability of our observations to other E3s. A comparison of the E3 activity with the two different E2s identified an additional variant that exhibits E3:E2 specificity. Our results highlight the general utility of high-throughput mutagenesis in delineating the molecular basis of enzyme activity.

Indexed as

Models, MolecularAllosteric RegulationAmino Acid SequenceAnimalsBlotting, WesternCell Surface Display TechniquesHigh-Throughput Screening AssaysImmunoprecipitationMiceMolecular Sequence DataMutagenesisNuclear Magnetic Resonance, BiomolecularOligonucleotidesSequence AlignmentUbiquitinUbiquitin-Protein LigasesOligonucleotidesUbe4b protein, mouseUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID23509263
PMCPMC3619334
OpenAlexW2010053735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.